Literature DB >> 21127983

Potential role of Neuregulin 1 and TNF-alpha (-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan.

Mamoona Naz1, Maria Riaz, Mahjabeen Saleem.   

Abstract

Schizophrenia is a chronic and disabling disease of the brain. Schizophrenic patients have auditory hallucinations, delusions and reduced social skills. Recent studies suggest that the genetic polymorphisms are linked with development of schizophrenia. Polymorphisms of schizophrenia susceptibility and different cytokine genes act as the genetic markers. The objective of our study is to examine the association between the neuregulin 1 and tumor necrosis factor-α (-308) gene polymorphism with schizophrenia. This association was performed on the basis of molecular biology to screen the mutations of neuregulin 1 and tumor necrosis factor-α (-308) gene in schizophrenic patients by polymorphism analysis. Statistical analysis of the observed data shows that there was an association (P = 0.003) between patient's group and controls in terms of genotypes of single-nucleotide polymorphism 1 rather than single-nucleotide polymorphism 2 of neuregulin 1. So, heterozygous (adenine/guanine) allelic pattern can be a higher risk factor of schizophrenic patients. Polymorphism of tumor necrosis factor-α (-308) gene indicated frequent presence of homozygous (adenine/adenine) allelic pattern in patient's group than in controls (P = 0.015). Statistical analysis indicates that the age distribution has significant difference between patient's group and controls (P = 0.022) while the gender ratio is not significantly different (P = 0.366) between the two groups. It was concluded that in Pakistani population the neuregulin 1 and tumor necrosis factor-α (-308) genes are strongly associated with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127983     DOI: 10.1007/s11033-010-0606-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  17 in total

Review 1.  Cytokines and the brain: implications for clinical psychiatry.

Authors:  Z Kronfol; D G Remick
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

2.  Schizophrenia, IV: neuregulin-1 in the human brain.

Authors:  Amanda Law
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112

Review 3.  Schizophrenia.

Authors:  Robert Freedman
Journal:  N Engl J Med       Date:  2003-10-30       Impact factor: 91.245

4.  Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia.

Authors:  J Kowalski; P Blada; K Kucia; A Madej; Z S Herman
Journal:  Schizophr Res       Date:  2001-07-01       Impact factor: 4.939

5.  Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia.

Authors:  F Boin; R Zanardini; R Pioli; C A Altamura; M Maes; M Gennarelli
Journal:  Mol Psychiatry       Date:  2001-01       Impact factor: 15.992

6.  Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus.

Authors:  Y Liu; B Ford; M A Mann; G D Fischbach
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

7.  The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations.

Authors:  D Hall; J A Gogos; M Karayiorgou
Journal:  Genes Brain Behav       Date:  2004-08       Impact factor: 3.449

8.  Association study of neuregulin 1 gene with schizophrenia.

Authors:  J Z Yang; T M Si; Y Ruan; Y S Ling; Y H Han; X L Wang; M Zhou; H Y Zhang; Q M Kong; C Liu; D R Zhang; Y Q Yu; S Z Liu; G Z Ju; L Shu; D L Ma; D Zhang
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain.

Authors:  A J Law; C Shannon Weickert; T M Hyde; J E Kleinman; P J Harrison
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  9 in total

1.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

2.  A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.

Authors:  Vinita Jagannath; Miriam Gerstenberg; Christoph U Correll; Susanne Walitza; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

3.  Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative stress, neurochemistry, psychopathology, and extrapyramidal symptoms in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Marko Saje; Katja Goričar; Vita Dolžan; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Neurochem Res       Date:  2012-12-02       Impact factor: 3.996

4.  Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample.

Authors:  Prachi Kukshal; Triptish Bhatia; A M Bhagwat; Raquel E Gur; Ruben C Gur; Smita N Deshpande; Vishwajit L Nimgaonkar; B K Thelma
Journal:  Schizophr Res       Date:  2013-01-26       Impact factor: 4.939

5.  Subchronic peripheral neuregulin-1 increases ventral hippocampal neurogenesis and induces antidepressant-like effects.

Authors:  Ian Mahar; Stephanie Tan; Maria Antonietta Davoli; Sergio Dominguez-Lopez; Calvin Qiang; Adeline Rachalski; Gustavo Turecki; Naguib Mechawar
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

6.  Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia.

Authors:  Saeed Kadasah; Misbahul Arfin; Sadaf Rizvi; Mohammed Al-Asmari; Abdulrahman Al-Asmari
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-12       Impact factor: 2.570

Review 7.  Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Authors:  C Gragnoli; G M Reeves; J Reazer; T T Postolache
Journal:  Transl Psychiatry       Date:  2016-04-19       Impact factor: 6.222

Review 8.  BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia.

Authors:  Zhengrong Zhang; Jing Huang; Yong Shen; Rena Li
Journal:  Front Mol Neurosci       Date:  2017-09-25       Impact factor: 5.639

9.  Association between TNF-alpha polymorphism and the age of first suicide attempt in chronic patients with schizophrenia.

Authors:  Xiaoe Lang; Tammy H Trihn; Hanjing Emily Wu; Yongsheng Tong; Meihong Xiu; Xiang Yang Zhang
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.